Name | 6-[2-(3,4-diethoxyphenyl)-1,3-thiazol-4-yl]pyridine-2-carboxylic acid |
---|---|
Synonyms |
Tetomilast
2-Pyridinecarboxylic acid, 6-[5-(3,4-diethoxyphenyl)-3-thienyl]- UNII-S6RXB5KF56 6-[5-(3,4-Diethoxyphenyl)-3-thienyl]-2-pyridinecarboxylic acid 6-[2-(3,4-diethoxypheny)-1,3-thiazol-4-yl]pyridine-2-carboxylic acid |
Description | Tetomilast (OPC-6535) is a PDE4 inhibitor with potential for the treatment of inflammatory bowel disease (IBD) and chronic obstructive pulmonary disease (COPD). |
---|---|
Related Catalog | |
References |
Density | 1.2±0.1 g/cm3 |
---|---|
Boiling Point | 526.1±50.0 °C at 760 mmHg |
Molecular Formula | C19H18N2O4S |
Molecular Weight | 369.434 |
Flash Point | 272.0±30.1 °C |
Exact Mass | 369.103485 |
PSA | 109.78000 |
LogP | 4.39 |
Vapour Pressure | 0.0±1.5 mmHg at 25°C |
Index of Refraction | 1.601 |
HS Code | 2934100090 |
---|
Precursor 5 | |
---|---|
DownStream 0 |
HS Code | 2934100090 |
---|---|
Summary | 2934100090 other compounds containing an unfused thiazole ring (whether or not hydrogenated) in the structure VAT:17.0% Tax rebate rate:9.0% Supervision conditions:none MFN tariff:6.5% General tariff:20.0% |